Carnitine palmitoyltransferase II deficiency

Jump to: navigation, search

WikiDoc Resources for Carnitine palmitoyltransferase II deficiency

Articles

Most recent articles on Carnitine palmitoyltransferase II deficiency

Most cited articles on Carnitine palmitoyltransferase II deficiency

Review articles on Carnitine palmitoyltransferase II deficiency

Articles on Carnitine palmitoyltransferase II deficiency in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Carnitine palmitoyltransferase II deficiency

Images of Carnitine palmitoyltransferase II deficiency

Photos of Carnitine palmitoyltransferase II deficiency

Podcasts & MP3s on Carnitine palmitoyltransferase II deficiency

Videos on Carnitine palmitoyltransferase II deficiency

Evidence Based Medicine

Cochrane Collaboration on Carnitine palmitoyltransferase II deficiency

Bandolier on Carnitine palmitoyltransferase II deficiency

TRIP on Carnitine palmitoyltransferase II deficiency

Clinical Trials

Ongoing Trials on Carnitine palmitoyltransferase II deficiency at Clinical Trials.gov

Trial results on Carnitine palmitoyltransferase II deficiency

Clinical Trials on Carnitine palmitoyltransferase II deficiency at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Carnitine palmitoyltransferase II deficiency

NICE Guidance on Carnitine palmitoyltransferase II deficiency

NHS PRODIGY Guidance

FDA on Carnitine palmitoyltransferase II deficiency

CDC on Carnitine palmitoyltransferase II deficiency

Books

Books on Carnitine palmitoyltransferase II deficiency

News

Carnitine palmitoyltransferase II deficiency in the news

Be alerted to news on Carnitine palmitoyltransferase II deficiency

News trends on Carnitine palmitoyltransferase II deficiency

Commentary

Blogs on Carnitine palmitoyltransferase II deficiency

Definitions

Definitions of Carnitine palmitoyltransferase II deficiency

Patient Resources / Community

Patient resources on Carnitine palmitoyltransferase II deficiency

Discussion groups on Carnitine palmitoyltransferase II deficiency

Patient Handouts on Carnitine palmitoyltransferase II deficiency

Directions to Hospitals Treating Carnitine palmitoyltransferase II deficiency

Risk calculators and risk factors for Carnitine palmitoyltransferase II deficiency

Healthcare Provider Resources

Symptoms of Carnitine palmitoyltransferase II deficiency

Causes & Risk Factors for Carnitine palmitoyltransferase II deficiency

Diagnostic studies for Carnitine palmitoyltransferase II deficiency

Treatment of Carnitine palmitoyltransferase II deficiency

Continuing Medical Education (CME)

CME Programs on Carnitine palmitoyltransferase II deficiency

International

Carnitine palmitoyltransferase II deficiency en Espanol

Carnitine palmitoyltransferase II deficiency en Francais

Business

Carnitine palmitoyltransferase II deficiency in the Marketplace

Patents on Carnitine palmitoyltransferase II deficiency

Experimental / Informatics

List of terms related to Carnitine palmitoyltransferase II deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Carnitine palmitoyltransferase II deficiency
Carnitine structure.png
Carnitine
ICD-9 277.85
OMIM 255110
DiseasesDB 32534
eMedicine ped/321 

Overview

Carnitine palmitoyltransferase II deficiency is a condition that prevents the body from converting certain fats called long-chain fatty acids into energy, particularly during periods without food. Carnitine, a natural substance acquired mostly through the diet, is used by cells to process fats and produce energy. People with this disorder have a faulty enzyme that prevents these fats from being processed in the mitochondria.

Classification

Types

There are three main types of carnitine palmitoyltransferase II deficiency:

  • a lethal neonatal form
  • a severe infantile hepatocardiomuscular form,
  • a myopathic form

Neonatal form

Infants with the lethal neonatal form of this disorder usually experience respiratory failure, liver failure, seizures, and an irregular heart beat leading to cardiac arrest. In many cases, patients have malformed features and an abnormally developed brain and kidneys.

Hepatocardiomuscular type

Signs and symptoms of the infantile hepatocardiomuscular type usually appear between 6 and 24 months of age. This condition involves recurring attacks of abnormally low levels of fat breakdown products and blood sugar (hypoketotic hypoglycemia) causing a loss of consciousness and seizures. Liver failure and an enlarged liver (hepatomegaly) are also sometimes seen. In many cases, there is also heart involvement. Episodes are often triggered by infections, fever, or fasting.

Myopathic form

The myopathic form is the most frequently seen and least severe form of carnitine palmitoyltransferase II deficiency. It has a variable age of onset and is characterized by muscle pain (myalgia) and weakness. This condition is sometimes associated with the abnormal breakdown of an oxygen-binding muscle protein called myoglobin (myoglobinuria). Myoglobinuria can cause kidney failure and death.

Causes

Mutations in the CPT2 gene cause carnitine palmitoyltransferase II deficiency, leading to the production of a defective version of an enzyme called carnitine palmitoyltransferase II.

Without this enzyme, long-chain fatty acids from food and fats stored in the body cannot be broken down and processed.

Excessive levels of long-chain fatty acids may build up in tissues, damaging the heart, liver, and muscles and causing more serious complications.

This condition is inherited in an autosomal recessive pattern.

See also

This article incorporates public domain text from The U.S. National Library of Medicine

References



Linked-in.jpg